Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. | Genome Med | 2021 | 33441124 | PubTator, text mining | PubMed |
| Insights into the theranostic value of precision medicine on advanced radiotherapy to breast cancer. | Int J Med Sci | 2021 | 33437197 | PubTator, text mining | PubMed |
| The Role of Noncoding RNAs in the Regulation of Anoikis and Anchorage-Independent Growth in Cancer. | Int J Mol Sci | 2021 | 33435156 | PubTator, text mining | PubMed |
| HIF in Nephrotoxicity during Cisplatin Chemotherapy: Regulation, Function and Therapeutic Potential. | Cancers (Basel) | 2021 | 33430279 | PubTator, text mining | PubMed |
| Transcriptomic landscaping of core genes and pathways of mild and severe psoriasis vulgaris. | Int J Mol Med | 2021 | 33416099 | PubTator, text mining | PubMed |
| Interplay between p53 and non-coding RNAs in the regulation of EMT in breast cancer. | Cell Death Dis | 2021 | 33414456 | PubTator, text mining | PubMed |
| STAT3 plays an important role in DNA replication by turning on WDHD1. | Cell Biosci | 2021 | 33413624 | PubTator, text mining | PubMed |
| Kinome inhibition reveals a role for polo-like kinase 1 in targeting post-transcriptional control in cancer. | Mol Oncol | 2021 | 33411958 | PubTator, text mining | PubMed |
| MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit. | NPJ Breast Cancer | 2021 | 33398005 | PubTator, text mining | PubMed |
| White button mushroom (Agaricus bisporus) disrupts androgen receptor signaling in human prostate cancer cells and patient-derived xenograft. | J Nutr Biochem | 2021 | 33388344 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| Hemodynamic and transcriptomic studies suggest early left ventricular dysfunction in a preclinical model of severe mitral regurgitation. | J Thorac Cardiovasc Surg | 2021 | 33277035 | PubTator, text mining | PubMed |
| Proteomics and phosphoproteomics reveal key regulators associated with cytostatic effect of amino acid transporter LAT1 inhibitor. | Cancer Sci | 2021 | 33264461 | PubTator, text mining | PubMed |
| The Nexus of Endocrine Signaling and Cancer: How Steroid Hormones Influence Genomic Stability. | Endocrinology | 2021 | 33260197 | PubTator, text mining | PubMed |
| Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer. | Cancer Med | 2021 | 33259133 | PubTator, text mining | PubMed |
| Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis. | Cell Mol Gastroenterol Hepatol | 2021 | 33232824 | PubTator, text mining | PubMed |
| Data mining combined with experiments to validate CEP55 as a prognostic biomarker in colorectal cancer. | Immun Inflamm Dis | 2021 | 33190424 | PubTator, text mining | PubMed |
| AXL Inhibition Induces DNA Damage and Replication Stress in Non-Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors. | Mol Cancer Res | 2021 | 33172976 | PubTator, text mining | PubMed |
| Aggressive B-cell Lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents. | Mol Cancer Res | 2021 | 33154093 | PubTator, text mining | PubMed |
| Ubiquitin signaling in cell cycle control and tumorigenesis. | Cell Death Differ | 2021 | 33130827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=51